Mizuho Securities Raises Price Target on Ironwood Pharma (IRWD) Following 3Q Beat

November 4, 2016 7:38 AM

Mizuho Securities reiterated a Buy rating on Ironwood Pharmaceuticals (NASDAQ: IRWD), and raised the price target to $20.00 (from $19.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found